期刊文献+

葛根素对实验性脑缺血GAD67mRNA表达变化的影响 被引量:4

Effects of puerarin on the expression of GAD67mRNA after experimental cerebral ischemic damage in rats
在线阅读 下载PDF
导出
摘要 目的观察葛根素对实验性脑缺血谷氨酸脱羧酶(GAD67)表达变化的影响。方法应用原位杂交方法检测大鼠永久大脑中动脉闭塞(MCAO)模型GAD67mRNA在脑缺血后不同时间的表达。结果正常组及假手术组GAD67mRNA在脑组织中表达较弱。对照组和治疗组GAD67mRNA在脑缺血后6h即开始表达增强,在72h 达高峰,后逐渐下降,GAD67mRNA表达至第2周仍高于正常,治疗组GAD67mRNA表达高于对照组。结论葛根素可以促进实验性脑缺血后GAD67mRNA的表达,具有神经保护作用,有助于神经功能的恢复。 Objective To study the expression of GAD67mRNA after experimental cerebral ischemic damage in rats and explore the neuroproteetive role of puerarin. Methods 84 healthy Wistar rats were recruited to estab lish the middle cerebral artery occlusion (MCAO) model by the ligation of the right carotid artery. The focal is chemic tissue was fixed ,dehydrated ,and paraffin-embedded in regular way at the time 6h,1d,3d,Sd,Td and 14d af ter the occlusion of MCA respectively. The gene expression of GAD in focal ischemic tissue of different times was assayed by in situ hybridization (ISH). Results The results of ISH revealed that the expression of (;AI)67mRNA was not so high as in the common brain tissue. The gene expression of GAD67 in the controlled and treatment group increased from 6h after the MCAO,and reached their peaks at the time of 72h after ischemia,then declined gradually. The gene expression of GAD67 was higher than that of normal group after 2w. The gene expression of GAD67 in the treatment group was more than that of controlled group. Conclusion Puerarin can promote the gene expression of GAD67. It is neuroprotective and is good to the rehibition of the neurological function.
作者 齐中华 刘群
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2006年第2期207-209,共3页 Journal of Apoplexy and Nervous Diseases
关键词 脑缺血 谷氨酸脱羧酶 葛根素 Puerarin GAD67 Cerebral ischemia
  • 相关文献

参考文献12

  • 1Sawada H,Shimobama S.Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons[J].Neurosci Biobehav Rev,2000,24(1):143-147.
  • 2Longa ZE,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20:84-91.
  • 3Hutchison PJ,Connell MT,Al-Rawi PG,et al.Increases in GABA concentrations during cerebral ischemia:a microdialysis study of extracellular amino acids[J].J Neurol Neurosurg Psychiatry,2002,72:99-105.
  • 4Benson DL,Huntsman MM,Jones EG.Activity-dependent changes in GAD and preprotachykinin mRNA in visual cortex of adult monkeys[J].Cerebcortex,1994,4:40-51.
  • 5Kulinskii VI,Mikhel'son GV.The Neuroprotective effect of GABA-ergic substances in cerebral isehemia[J].Eksp Klin Farmakol,1997,60(1):56-58.
  • 6Kato H,Kogure K.Biochemical and molecular characteristics of the brain with developing cerebral infarction[J].Cell and Mol Neurobiol,1999,19:93-108.
  • 7Nakanishi H,Tamura A,Kawai K,et al.Electrophysiologic studies of rat substantia nigra neurons in vitro slice preparation after middle cerebral artery ocllusion[J].Neuroscience,1997,77 (4):1021-1028.
  • 8Ferm R,Wasnan SG,Ransom BR.Modulation of anxoxic injury in CNS white matter by adenosine,and interaction between adenosine and GABA[J].J Neurophysiol,1995,72:2609-2616.
  • 9Oregan MH,Song D,Vanderheide SJ,et al.Free radicals and the ischemia evoked extracellular accumulation of amino acids in rat cerebral cortex[J].Neurochem Res,1997,22(3):273-280.
  • 10Shuaib A,Ijaz MS,Miyashita H,et al.GABA and glutamate levels in the substantia nigra reticulation following repeatitive cerebral ischemia in gerbils[J].Exp Neurol,1997,147(2):311-315.

二级参考文献9

  • 1[1]Richerd-E, Heikkila. RE, Hessand. RC, Duvoisin. Dopaminergic. neurotoxicity. of. 1-Methyl-4-Pheny1-1, 2, 3, 6-Tetrahydropyridine in mice. Science, 1984,224:1451~1453
  • 2[2]Arai-N, Misugi-K, Goshima-Y, et al. Evaluation-of-1-Methy1-4-Pheny1-1, 2, 3, 6-Tetahyd ropyridine(MPTP)-treatedC57-black-mouse-for-Parkinsonism[J]. Brain-Res. 1990, May7, 515(1-2):57~63
  • 3[3]Shepherd JE.Effects of estrogenon congnition, mood, and degenerative brain diseases. J Am Pharm Assoc(Wash)2001 Mar-Apr, 41(2):221~8
  • 4[4]Patisaul HB, Dindo M, Whitten PL, et al. Soy Isoflavone supplements Antagonize Reproductive Behavior and Estrogen Receptor alpha-and beta-Dependent Gene Expression in the Brain. Endoctinology, 2001,Jul,142(7):2946~52
  • 5[5]Cyr M, Calon F, Morissette M, et al. Drugs with estrogen-like potencu and brain activity: potential therapeutic application for the CNS. Cur Pharm Des, 2000 Aug, 6(12):1287~312
  • 6[6]Knight DC, Eden A. Areview of the clinical effects of phyto-estrogens. Obstetrics Ggnecology, 1996,87(5):897~904
  • 7[7]Sawada H, Shimobama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neuron. Neurosci Biobehav. Rev, 2000,Jan,24(1):143~147
  • 8[8]Sawada H, Ibi M, Kihara T. et al. Estradiol proeects mesencephalic dopaminergic neurons from oxidative stress-induced-neuronal death. J Neurosci Res.1998,Dec1,54(5):707~19
  • 9[9]Sawada H, Tbi M, Kihara T, et al. Mechenisms of antiapoptotic effects of estrogens in dopaminergic neurons. FASEB J, 2000,Jun,14(9):1202~20

共引文献34

同被引文献83

引证文献4

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部